Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

VistaShares Target 15 USA Quality Income ETF (NY:QUSA)

18.09 -0.01 (-0.06%)
Streaming Delayed Price Updated: 12:24 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about VistaShares Target 15 USA Quality Income ETF

News headline image
Lululemon’s US Sales Struggles Are Likely To Extend Into 2026 Despite CEO Reset, Warns UBS ↗
Lululemon’s net revenue from the U.S. region fell 2% in its Q3 earnings due to slowing consumer demand amid macro uncertainties. 
Via Stocktwits
Topics Economy World Trade
News headline image
Meta Acquires Singapore-Based Startup To Enhance AI-Capability For Undisclosed Sum ↗
Manus is focused on building a general-purpose AI agent designed to help users tackle research, automation, and complex tasks. 
Via Stocktwits
Topics Artificial Intelligence Supply Chain
News headline image
Lululemon Founder Targets Board Change Ahead Of CEO Search: Report ↗
Proposal seeks to make boardroom revisions before athletic-apparel company chooses a new CEO, report said. 
Via Stocktwits
News headline image
Why Analysts See Nvidia’s Groq Licensing Deal As A Clear Win For AI Leadership ↗
Despite the reported $20 billion price tag, brokerages believe the deal is small relative to Nvidia's scale and long-term earnings power. 
Via Stocktwits
Topics Artificial Intelligence
Jefferies' Randy Konik Sees Nike Getting 'Its Act Together' Under CEO Elliott Hill ↗
Via Stocktwits
Nike Turnaround Faces A Longer Road Despite Brand Strength, UBS Says ↗
Via Stocktwits
Pentagon Blames Lockheed Martin For F-35’s Lack Of Availability ↗
Via Stocktwits
News headline image
Johnson & Johnson Terminates Experimental Eczema Drug Study After It Fails To Show Benefit ↗
The company said that the drug did not achieve the “high-bar””efficacy targets in a planned interim analysis. 
Via Stocktwits
News headline image
Meta Sees Another Board Shakeup As Former Trump Adviser Resigns Just Months After Joining ↗
Meta said in a filing with the Securities and Exchange Commission that Powell McCormick notified the company on Friday that she will resign effective immediately. 
Via Stocktwits
Topics Artificial Intelligence Government
News headline image
Eli Lilly’s Oral Obesity Drug Passes Maintenance Test After Wegovy, Zepbound — Wall Street Flags Win For Viking Therapeutics ↗
Lilly’s Orforglipron is eligible for a fast-track review by the FDA in treating obesity. 
Via Stocktwits
News headline image
Lam Research Stock Saw A Price Target Hike From B. Riley – What’s The Driving Factor? ↗
B. Riley raised its price target on Lam Research to $195 from $180. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Merck Scores FDA Fast-Track Review For Key Cholesterol And Cancer Drugs With Multibillion-Dollar Potential: Report ↗
While one of the drugs reportedly slated for fast-track review is the cholesterol pill Enlicitide decanoate, the other is its cancer therapy Sacituzumab tirumotecan. 
Via Stocktwits
News headline image
Oracle Denies Data Center Delay Report After Shares Slide On OpenAI Build-Out Concerns ↗
Oracle and OpenAI struck a $300 billion contract in September, with the former agreeing to build out data centers with a total capacity of 4.5 gigawatts. 
Via Stocktwits
Topics Artificial Intelligence Earnings
News headline image
Costco Stock Dips After Hours Despite Strong Q1 And Holiday Momentum — Retail Bulls Eye Rally Next Week ↗
The company reported adjusted earnings per share of $4.50, above an analyst estimate of $4.27, according to data from Fiscal AI. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Illinois Tool Works Tightens Profit Outlook As US Tariffs Stir Supply Concerns ↗
ITW (NYSE: ITW) shares down after reporting Q3 results and narrowing guidance. Revenue up 2.3%, operating margin improved. 
Via Benzinga
News headline image
Viking Therapeutics Stock Soars After Morgan Stanley’s Price Target Implies A Potential 225% Upside ↗
Morgan Stanley raised its price target on VKTX to $102 from $98 while maintaining an ‘Overweight’ rating. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Fastenal Profit Underwhelms Despite Higher Customer Spending ↗
Fastenal (NASDAQ: FAST) Q3 revenue beats estimates at $2.13B, but EPS misses by a cent; shares slide 4% premarket. 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.